Iris Dorbian

Iris Dorbian

HLM Venture Partners snags $63.7 mln for fourth fund

HLM Venture Partners has raised $63.7 million for its fourth fund, according to an SEC filing. The target is $125 million.

1 min read · 30 December 2015

Lifesize spins off from Logitech, grabs $17.5 mln

Lifesize, a video communications solutions provider, has spun off from Logitech International and raised $17.5 million in funding . The new private company's investors are Redpoint Ventures, Sutter Hill Ventures and Meritech Capital Partners. Logitech will retain a stake in Lifesize.

2 min read · 30 December 2015

New York startup DipJar picks up $2.4 mln seed

New York-based DipJar, a provider of tip jars and donation boxes for credit cards, has raised $2.4 million in seed funding. The investors included Bolt, Project 11, Corazon Capital and Charge Ventures.

2 min read · 28 December 2015

Video platform Innovid nabs $27.5 mln

Video platform Innovid has secured $27.5 million in funding. The investors included New Spring Capital, Sequoia Capital Israel, Genesis Partners, Cisco Ventures, T-Venture, Vintage Investment Partners, Silicon Valley Bank and TriplePoint Capital.

3 min read · 28 December 2015

Sopris Capital leads Series A round for HealPros

HealPros LLC, a provider of mobile diabetic eye examinations, has secured an undisclosed amount of Series A funding. Sopris Capital led the round.

3 min read · 28 December 2015

Passion Capital backs HomeTouch

Passion Capital has provided undisclosed venture funding to HomeTouch. Based in the UK, HomeTouch is an online home care platform.

3 min read · 23 December 2015

InnFocus scores $33.9 mln Series C

InnFocus Inc, which focuses on treating glaucoma, has raised $33.9 million in Series C funding. The investors were not named.

2 min read · 23 December 2015

India startup Shuttl drives away with $20 mln Series A

India-based bus aggregator platform Shuttl has secured $20 million in Series A funding. The investors were Lightspeed, Sequoia India and Times Internet Ltd.

3 min read · 23 December 2015

eFFECTOR Therapeutics nabs $40 mln Series B

San Diego-based eFFECTOR Therapeutics, a biopharmaceutical company focused on treating cancer, has raised $40 million in Series B funding. The investors were Altitude Life Science Ventures, AbbVie Biotech Ventures, BioMed Ventures, Abingworth, Novartis Venture Fund, SR One, The Column Group, US Venture Partners, Astellas Ventures, Osage University Partners and Mission Bay Capital. In addition to the funding, eFFECTOR has named Dave Maki, managing partner of Altitude Life Science Ventures, to its board of directors.

3 min read · 22 December 2015

Motorola Solutions backs BlueLine Grid

BlueLine Grid has secured undisclosed funding from Motorola Solutions Venture Capital. BlueLine Grid is a network provider for law enforcement, first responders and security teams.

2 min read · 22 December 2015

Showing 4,971 to 4,980 of 7,132 results
1…497499…714